Geode Capital Management
AVTX icon

Geode Capital Management’s Avalo Therapeutics AVTX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$552K Buy
110,460
+2,648
+2% +$13.2K ﹤0.01% 3526
2025
Q1
$864K Buy
107,812
+2,959
+3% +$23.7K ﹤0.01% 3353
2024
Q4
$779K Buy
104,853
+94,742
+937% +$704K ﹤0.01% 3453
2024
Q3
$95.6K Buy
+10,111
New +$95.6K ﹤0.01% 4116
2023
Q4
Sell
-133,518
Closed -$16.1K 4656
2023
Q3
$16.1K Buy
133,518
+52,548
+65% +$6.34K ﹤0.01% 4666
2023
Q2
$28.8K Buy
80,970
+29,638
+58% +$10.5K ﹤0.01% 4604
2023
Q1
$89.8K Hold
51,332
﹤0.01% 4381
2022
Q4
$261K Sell
51,332
-88
-0.2% -$447 ﹤0.01% 3948
2022
Q3
$170K Sell
51,420
-794,969
-94% -$2.63M ﹤0.01% 4300
2022
Q2
$423K Sell
846,389
-516,540
-38% -$258K ﹤0.01% 3853
2022
Q1
$987K Buy
1,362,929
+35,358
+3% +$25.6K ﹤0.01% 3625
2021
Q4
$2.26M Buy
1,327,571
+85,189
+7% +$145K ﹤0.01% 3311
2021
Q3
$2.71M Sell
1,242,382
-67,576
-5% -$147K ﹤0.01% 3224
2021
Q2
$4.28M Buy
1,309,958
+254,628
+24% +$833K ﹤0.01% 3001
2021
Q1
$3.19M Buy
1,055,330
+360,329
+52% +$1.09M ﹤0.01% 3011
2020
Q4
$1.83M Buy
695,001
+58,047
+9% +$153K ﹤0.01% 3129
2020
Q3
$1.45M Buy
636,954
+268,691
+73% +$611K ﹤0.01% 3052
2020
Q2
$957K Buy
368,263
+102,683
+39% +$267K ﹤0.01% 3151
2020
Q1
$658K Buy
265,580
+24,774
+10% +$61.4K ﹤0.01% 3181
2019
Q4
$1.3M Buy
240,806
+1,757
+0.7% +$9.46K ﹤0.01% 3174
2019
Q3
$786K Buy
239,049
+6,266
+3% +$20.6K ﹤0.01% 3317
2019
Q2
$1.27M Buy
232,783
+107,605
+86% +$585K ﹤0.01% 3159
2019
Q1
$731K Buy
125,178
+30,188
+32% +$176K ﹤0.01% 3287
2018
Q4
$306K Buy
94,990
+31,951
+51% +$103K ﹤0.01% 3545
2018
Q3
$294K Hold
63,039
﹤0.01% 3632
2018
Q2
$273K Hold
63,039
﹤0.01% 3633
2018
Q1
$270K Buy
63,039
+43,623
+225% +$187K ﹤0.01% 3599
2017
Q4
$62K Buy
+19,416
New +$62K ﹤0.01% 3897